J2786
HCPCSInjection, reslizumab, 1mg
Official HCPCS Level II long descriptor
Injection, reslizumab, 1 mg
HCPCS Level II code J2786 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Injection, reslizumab, 1mg
Added to HCPCS: 2017-01-01
Nearby codes in J2
- J2770Quinupristin/dalfopristin
- J2777Inj, faricimab-svoa, 0.1mg
- J2778Ranibizumab injection
- J2779Inj, susvimo 0.1 mg
- J2781Inj, pegcetacoplan, 1mg
- J2782Inj avacincaptad pegol 0.1mg
- J2783Rasburicase
- J2785Regadenoson injection
- J2787Riboflavin photrexa/viscous
- J2788Rho d immune globulin 50 mcg
- J2789Riboflavin epioxa/hd<=2ml
- J2790Rho d immune globulin inj
- J2791Rhophylac injection
- J2792Rho(d) immune globulin h, sd
- J2793Rilonacept injection
- J2794Inj risperdal consta, 0.5 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.